Mei‐Yu Jang

626 citations
36 papers · 453 indexed · h-index 12
Topics
Urinary Bladder and Prostate Research (13 papers)Urological Disorders and Treatments (9 papers)Bladder and Urothelial Cancer Treatments (6 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEThe Journal of Urology
Partner nations
TaiwanUnited States

In The Last Decade

Mei‐Yu Jang

35 papers receiving 440 citations

Peers

Mei‐Yu Jang
Comparison fields: 5 of 78
  • Surgery 161
  • Urology 128
  • Pulmonary and Respiratory Medicine 110
  • Rheumatology 102
  • Pharmacology 90
Replace Hui-Yun Gu with:
Hui-Yun Gu China
David Burks United States
Christopher L. Chan United Kingdom
Vivekanand Singh United States
Mustafa Yılmaz Türkiye
Jukka Sairanen Finland
Chih‐Hao Shen Taiwan
Erez Lang Israel
Vincenzo Salvo Italy
Sean Mazer United States
Mei‐Yu Jang relative to Hui-Yun Gu China Hui-Yun Gu's profile →
Citations per field
00.5×11.6×
Hui-Yun Gu · 1×
Citations per year

Countries citing papers authored by Mei‐Yu Jang

Since Specialization
Citations

This map shows the geographic impact of Mei‐Yu Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Yu Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Yu Jang more than expected).

Fields of papers citing papers by Mei‐Yu Jang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐Yu Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Yu Jang. The network helps show where Mei‐Yu Jang may publish in the future.

Co-authorship network of co-authors of Mei‐Yu Jang

This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Yu Jang. A scholar is included among the top collaborators of Mei‐Yu Jang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Yu Jang. Mei‐Yu Jang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 18
3 5
4 25
5 5
6 15
7 5
8 12
9 61
10 29
11 10
12 19
13 6
14 1
15 12
16 4
17 8
18 7
19 8
20 6

About Mei‐Yu Jang

Mei‐Yu Jang is a scholar working on Urology, Biological Psychiatry and Rheumatology, having authored 36 papers that have together received 453 indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (13 papers), Urological Disorders and Treatments (9 papers) and Bladder and Urothelial Cancer Treatments (6 papers). The work is most often cited by research in Biological Psychiatry (82 citations), Urology (128 citations) and Rheumatology (102 citations). Mei‐Yu Jang has collaborated with scholars based in Taiwan and United States. Frequent co-authors include Wen‐Jeng Wu, Yung‐Shun Juan, Jung‐Tsung Shen, Shu‐Mien Chuang, Cheng‐Yu Long, Keh‐Min Liu, Yii‐Her Chou, Robert M. Levin, Chun‐Hsiung Huang and Chun‐Hsiung Huang. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026